Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic Signature of Breast Cancer Defines Therapeutic Interventions and Indicates Early Drug Resistance.

Journal of cellular and molecular medicine - 1 Jun 2025

Margoni Angeliki, Papavassiliou Kostas A, Papavassiliou Athanasios G

Abstract excerpt

Breast cancer (BC) is the most prevalent cancer in women and ranks first in diagnosed cancers worldwide, thanks to effective screening strategies. However, morbidity and mortality rates remain high among aggressive subtypes, forcing oncologists to adopt the philosophy of precision oncology in clinical practice. Immunohistochemical analysis of the tumour establishes diagnosis and stratifies BC into four types,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Resistance, Neoplasm

Share to High-Throughput Nucleotide Sequencing

Share to Mutation

Share to Precision Medicine

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 40434213
DOI: 10.1111/jcmm.70635
PMCID: PMC12117919

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 17 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic Signature of Breast Cancer Defines Therapeutic Interventions and Indicates Early Drug Resistance.PMID 40434213Read ↗

Breast Cancer: Epidemiology, Molecular Classification, Diagnostics and Evolving Treatment Paradigms.Semantic proximity Read ↗

Breast Cancer: A Molecularly Heterogenous Disease Needing Subtype-Specific TreatmentsSemantic proximity Read ↗

Current advances in the diagnosis and personalized treatment of breast cancer: lessons from tumor biology.Semantic proximity Read ↗

Molecular Pathology of Breast Tumors: Diagnostic and Actionable Genetic Alterations.Semantic proximity Read ↗

Molecular Pathology of Breast Tumors: Diagnostic and Actionable Genetic Alterations.Semantic proximity Read ↗

Recent advances of therapeutic targets based on the molecular signature in breast cancer: genetic mutations and implications for current treatment paradigmsSemantic proximity Read ↗

The Influence of Cancer Molecular Subtypes and Treatment on the Mutation Spectrum in Metastatic Breast Cancers.Semantic proximity Read ↗

The Multi-Omic Transformation of Breast Cancer Diagnostics: A Comprehensive Review of the Transition from Immunohistochemistry to Liquid Biopsy and Next-Generation SequencingSemantic proximity Read ↗

The importance of molecular markers for diagnosis and selection of targeted treatments in patients with cancerSemantic proximity Read ↗

Precision medicine in breast cancer: genes, genomes, and the future of genomically driven treatments.Semantic proximity Read ↗

How shall we treat early triple-negative breast cancer (TNBC): from the current standard to upcoming immuno-molecular strategiesSemantic proximity Read ↗

Breast cancer biomarkers and molecular medicine.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.